Get started
GRAIL, Inc.GRAIL, Inc.GRAIL, Inc.

GRAIL, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Compare with GRAIL, Inc.



Key stats


Market capitalization
‪6.40 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−9.75 USD
Net income (FY)
‪−408.35 M‬ USD
Revenue (FY)
‪147.17 M‬ USD
Shares float
‪42.00 M‬
Beta (1Y)
1.99

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
910
Change (1Y)
−90−9.00%
Revenue / Employee (1Y)
‪161.73 K‬ USD
Net income / Employee (1Y)
‪−448.74 K‬ USD

Company info


Sector
Health Technology
Industry
Medical Specialties
CEO
Joshua J. Ofman
Website
grail.com
Headquarters
Menlo Park
Founded
2015
IPO date
Jun 12, 2024
ISIN
US3847471014
CUSIP
384747101
FIGI
BBG01N6CGW43
Identifiers
ISIN US3847471014
CFI code
ESVUFR
GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral

Analyst rating


An aggregate view of professional's ratings.
Neutral
Neutral
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IWM
iShares Russell 2000 Index Fund
Weight0.21%
Market value‪166.04 M‬
XBI
State Street SPDR S&P Biotech ETF
Weight1.40%
Market value‪140.57 M‬
IWN
iShares Russell 2000 Value ETF
Weight0.42%
Market value‪59.17 M‬
IBB
iShares Biotechnology ETF
Weight0.46%
Market value‪48.80 M‬
SCHA
Schwab U.S. Small-Cap ETF
Weight0.15%
Market value‪33.68 M‬
VXF
Vanguard Extended Market ETF
Weight0.03%
Market value‪30.02 M‬
VTWO
Vanguard Russell 2000 ETF
Weight0.10%
Market value‪18.85 M‬
D
DFAS
Dimensional U.S. Small Cap ETF
Weight0.12%
Market value‪18.24 M‬
D
DFAC
Dimensional U.S. Core Equity 2 ETF
Weight0.03%
Market value‪12.41 M‬
FESM
Fidelity Enhanced Small Cap Core ETF
Weight0.18%
Market value‪11.84 M‬
PSC
Principal U.S. Small-Cap ETF
Weight0.43%
Market value‪11.79 M‬

Explore more ETFs 

Frequently asked questions


The current price of GRAL is 154.08 USD — it has increased by 8.07% in the past 24 hours. Watch GRAIL, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GRAIL, Inc. stocks are traded under the ticker GRAL.
GRAL stock has risen by 16.00% compared to the previous week, the month change is a 79.07% rise, over the last year GRAIL, Inc. has showed a 129.97% increase.
We've gathered analysts' opinions on GRAIL, Inc. future price: according to them, GRAL price has a max estimate of 175.00 USD and a min estimate of 60.00 USD. Watch GRAL chart and read a more detailed GRAIL, Inc. stock forecast: see what analysts think of GRAIL, Inc. and suggest that you do with its stocks.
GRAL reached its all-time high on Sep 30, 2026 with the price of 151.46 USD, and its all-time low was 12.33 USD and was reached on Oct 7, 2024. View more price dynamics on GRAL chart.
See other stocks reaching their highest and lowest prices.
GRAL stock is 11.54% volatile and has beta coefficient of 1.99. Track GRAIL, Inc. stock price on the chart and check out the list of the most volatile stocks — is GRAIL, Inc. there?
Today GRAIL, Inc. has the market capitalization of ‪6.40 B‬, it has increased by 22.22% over the last week.
Yes, you can track GRAIL, Inc. financials in yearly and quarterly reports right on TradingView.
GRAIL, Inc. is going to release the next earnings report on Nov 18, 2026. Keep track of upcoming events with our Earnings Calendar.
GRAL earnings for the last quarter are −2.56 USD per share, whereas the estimation was −2.66 USD resulting in a 3.60% surprise. The estimated earnings for the next quarter are −2.50 USD per share. See more details about GRAIL, Inc. earnings.
GRAIL, Inc. revenue for the last quarter amounts to ‪44.69 M‬ USD, despite the estimated figure of ‪42.39 M‬ USD. In the next quarter, revenue is expected to reach ‪44.20 M‬ USD.
GRAL net income for the last quarter is ‪−110.25 M‬ USD, while the quarter before that showed ‪−93.19 M‬ USD of net income which accounts for 0.00% change. Track more GRAIL, Inc. financial stats to get the full picture.
No, GRAL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 6, 2026, the company has 910 employees. See our rating of the largest employees — is GRAIL, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRAIL, Inc. EBITDA is ‪−378.45 M‬ USD, and current EBITDA margin is −256.74%. See more stats in GRAIL, Inc. financial statements.
Like other stocks, GRAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRAIL, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRAIL, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRAIL, Inc. stock shows the strong buy signal. See more of GRAIL, Inc. technicals for a more comprehensive analysis.